WashingtonVotes.org
your lawmakers' votes at your fingertips
your lawmakers' votes at your fingertips
Legislation watch
2013 House Bill 1216: Concerning insurance coverage of treatment of eosinophilia gastrointestinal associated disorders
Introduced by Rep. Cyrus Habib (Kirkland) (D) on January 21, 2013
Requires that any disability insurance contract issued by the Insurance Commissioner after January 1, 2016 shall include formulas necessary for the treatment of eosinophilia gastrointestinal associated disorders. (See also SB5130). Official Text and Analysis.
Referred to the House Health Care & Wellness Committee on January 21, 2013
Substitute offered in the House on February 8, 2013
Removes the requirement that health carriers cover formulas necessary for
the treatment of eosinophilia gastrointestinal associated disorders and instead requires the
DOH to perform a sunrise review on the proposal.
Referred to the House Rules Committee on February 12, 2013
Requires the Department of Health to perform a sunrise review on a proposal
to require health carriers to cover formulas necessary for the treatment of
eosinophilia gastrointestinal associated disorders, regardless of delivery
method.
Received in the Senate on February 25, 2013
Referred to the Senate Health Care Committee on February 25, 2013
Amendment offered in the Senate on March 25, 2013
Adds a section providing that each carrier shall continue to apply a timely appeals and grievance process to ensure medically necessary treatment is available. Expedited appeals must be completed when a delay in the appeal process could jeopardize the enrollees' life, health, or ability to regain maximum function.
The amendment passed by voice vote in the Senate on April 12, 2013
Referred to the Senate Rules Committee on March 26, 2013
Received in the House on April 18, 2013
Motion in the House on April 18, 2013
To concur in Senate amendment(s).
The motion passed by voice vote in the House on April 18, 2013
Requires the Department of Health to perform a sunrise review on a proposal to require health carriers to cover formulas necessary for the treatment of eosinophilia gastrointestinal associated disorders, regardless of delivery method.
Signed by Gov. Jay Inslee on May 8, 2013